Ramesh J. Chougule

This article explains the strategic reasons behind organizations unable to reap benefits of their ERP investments.

Views on IT in Life Sciences industry, focusing on clinical trial space and how CROs can enhance their technology adoption.

For pharmaceutical businesses the past decade has been marked by turbulence and upheaval. The boom days when ‘blockbuster’ drugs earned their creators untold billions are now long past; the most lucrative patents have expired or are expiring. And in an industry where just one failed R&D project has the power to rock a company to its core, there will be no easy fixes or quick wins to replace lost revenue. But all is not doom and gloom however, and pharma companies can expect to find salvation in… Show more

For pharmaceutical businesses the past decade has been marked by turbulence and upheaval. The boom days when ‘blockbuster’ drugs earned their creators untold billions are now long past; the most lucrative patents have expired or are expiring. And in an industry where just one failed R&D project has the power to rock a company to its core, there will be no easy fixes or quick wins to replace lost revenue. But all is not doom and gloom however, and pharma companies can expect to find salvation in what has become one of their most important assets: their data estate Show less

For pharmaceutical companies, big data is about to get a whole lot bigger. This is because countries are scrambling to put in place vast systems to keep tabs on the manufacturing and distribution of prescription drugs. Faced with global counterfeiting ., governments are responding by establishing strict serialisation measures that mandate tracking the drug pipeline from start to finish. However, organizations need to see the business case beyond compliance and deep dive into opportunities to… Show more

For pharmaceutical companies, big data is about to get a whole lot bigger. This is because countries are scrambling to put in place vast systems to keep tabs on the manufacturing and distribution of prescription drugs. Faced with global counterfeiting ., governments are responding by establishing strict serialisation measures that mandate tracking the drug pipeline from start to finish. However, organizations need to see the business case beyond compliance and deep dive into opportunities to gain business efficiency.
Show less

Launched Infosys' CTSM solution on SAP HANA, Cloud and Mobile. It was the biggest launch from Infosys in Sapphire in past 10 years

A growing need for serialization is spreading around the globe. A reduction in ccounterfieting is clearly desirable but the implementation of successful solutions is not as easy as it might sound.

While there is a huge opportunity for Pharma Industry to expand in emerging markets, there are significant challenges in the process. The article provides insights into six areas of challenges for Pharma organizations.

Next Generation ERP systems will enable pharmaceutical companies to automate product lifecycle management and create a more holistic approach to drug discovery and development.

Product failure can be potentially fatal to a customer and have severe implications for manufacturers; however, many pharma companies still believe that complaint management is not related to the overall management of customer relationships

In order to have an efficient ERP system, there is a clear need for robust methodology, by coupling global delivery model with key service enablers, pharmaceutical companies can achieve a cost effective ERP application and benefit from a fully validated system.

Data driven framework for controlling manufacturing cost, modelling a manufacturing plant as a profit center inside its own boundries.

How to implement ERP in an environment where manufacturing is process as well as line manufacturing.

Presented a case study of a Pharmaceutical company to enhance e-commerce experience using HANA for vaccines business.

Presented the Pricing on HANA solution to eliminate pricing issues in high volume transactions business such as CPG, Retail and Pharma Distribution.

1.Challenges in Emerging Markets for Life Sciences Industry
2.How Will the Market Change in Five Years?
3.Infosys' Contribution from the Life Sciences Sector